GlassScriptPhysician profile
Kathleen E Rinkes
NPI 1336334598
$2,118.76
in general payments reported to CMS, 2019-2025
27 companies · $435 in 2025
The $435 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $90.76 · 2021: $176 · 2022: $413 · 2023: $309 · 2024: $355 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $275.94 | 2019-2025 | Veozah |
| Abbvie INC. | $275.79 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $256.22 | 2019-2025 | Aptima, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Organon LLC | $155.17 | 2021-2025 | Nexplanon, Jada System |
| Daiichi Sankyo INC. | $144.99 | 2019-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $133.96 | 2019-2025 | |
| Pfizer INC. | $128.24 | 2022-2024 | |
| Exeltis, USA INC. | $122.87 | 2021-2024 | Slynd |
| Sage Therapeutics, LLC | $119.51 | 2024-2025 | Zurzuvae |
| Ethicon US, LLC | $61.33 | 2019-2022 | |
| Amgen INC. | $53.97 | 2019-2023 | Prolia, Evenity |
| Mayne Pharma Commercial LLC | $40.89 | 2025 | |
| Exact Sciences Corporation | $39.33 | 2025 | Cologuard Collection Kit |
| Allergan, INC. | $38.71 | 2019 | |
| Minerva Surgical, INC | $34.43 | 2021-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $33.32 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $30.46 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Organogenesis INC. | $27.55 | 2025 | Puraply Wound Matrix |
| Myovant Sciences INC. | $22.00 | 2022 | |
| Agile Therapeutics, INC. | $18.46 | 2021 | |
| Convatec INC. | $17.24 | 2022 | |
| Shield Therapeutics INC | $16.32 | 2025 | |
| Sumitomo Pharma America, INC. | $15.95 | 2023 | Myfembree |
| Mylan Pharmaceuticals INC. | $15.94 | 2022 | |
| Duchesnay USA Incorporated | $15.10 | 2019 | |
| Boston Scientific Corporation | $13.07 | 2019 | |
| Lupin INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Rinkes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.